Overview

Pycnogenol for the Treatment of Lymphedema

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Pycnogenols